Synthesis, biological evaluation, and binding mode of novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles targeted at the HIV-1 reverse transcriptaseSILVESTRI, Romano; ARTICO, Marino; DE MARTINO, Gabriella et al.Journal of medicinal chemistry (Print). 2002, Vol 45, Num 8, pp 1567-1576, issn 0022-2623Article

Synthesis of novel N-1 (allyloxymethyl) analogues of 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (MKC-442, emivirine) with improved activity against HIV-1 and its mutantsEL-BROLLOSY, Nasser R; JØRGENSEN, Per T; DAHAN, Berit et al.Journal of medicinal chemistry (Print). 2002, Vol 45, Num 26, pp 5721-5726, issn 0022-2623, 6 p.Article

Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detectionVELDKAMP, A. I; VAN HEESWIJK, R. P. G; HOETELMANS, R. M. W et al.Journal of chromatography. B, Biomedical sciences and applications. 1999, Vol 727, Num 1-2, pp 151-157, issn 1387-2273Article

Clinical experience with adding delavirdine to combination therapy in patients in whom multiple antiretroviral treatment including protease inhibitors has failedBELLMAN, P. C.AIDS (London). 1998, Vol 12, Num 11, pp 1333-1340, issn 0269-9370Article

Metabolism of delavirdine, a human immunodeficiency virus type-1 reverse transcriptase inhibitor, by microsomal cytochrome P450 in humans, rats, and other species: Probable involvement of CYP2D6 and CYP3AVOORMAN, R. L; MAIO, S. M; HAUER, M. J et al.Drug metabolism and disposition. 1998, Vol 26, Num 7, pp 631-639, issn 0090-9556Article

Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two- and three-drug combinations of delavirdine, lamivudine and zidovudinePAGANO, P. J; CHONG, K. T.Antiviral chemistry & chemotherapy. 1997, Vol 8, Num 4, pp 333-341, issn 0956-3202Article

Twenty Years of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Time to Reevaluate their ToxicityBLAS-GARCIA, A; ESPLUGUES, J. V; APOSTOLOVA, N et al.Current medicinal chemistry. 2011, Vol 18, Num 14, pp 2186-2195, issn 0929-8673, 10 p.Article

Buprenorphine and HIV primary care: new opportunities for integrated treatmentKHALSA, Jag; VOCCI, Francis J; FIELLIN, David et al.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, 91 p., SUP4Conference Proceedings

Long-term pharmacokinetics of amprenavir in combination with delavirdine in HIV-infected childrenENGELHORN, C; HOFFMANN, F; KUROWSKI, M et al.AIDS (London). 2004, Vol 18, Num 10, pp 1473-1475, issn 0269-9370, 3 p.Article

Pharmacokinetics of ritonavir and delavirdine in human immunodeficiency virus-infected patientsSHELTON, Mark J; HEWITT, Ross G; ADAMS, John et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1694-1699, issn 0066-4804, 6 p.Article

Delavirdine increases drug exposure of ritonavir-boosted protease inhibitorsHARRIS, Marianne; ALEXANDER, Chris; O'SHAUGHNESSY, Michael et al.AIDS (London). 2002, Vol 16, Num 5, pp 798-799, issn 0269-9370Article

Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasmaPROUST, V; TOTH, K; HULIN, A et al.Journal of chromatography. B, Biomedical sciences and applications. 2000, Vol 742, Num 2, pp 453-458, issn 1387-2273Article

Delavirdine : A review of its use in HIV infectionSCOTT, Lesley J; PERRY, Caroline M.Drugs (Basel). 2000, Vol 60, Num 6, pp 1411-1444, issn 0012-6667Article

Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir : AIDS Clinical Trials Group Study 359GULICK, Roy M; HU, X. Joan; SNYDER, Sally et al.The Journal of infectious diseases. 2000, Vol 182, Num 5, pp 1375-1384, issn 0022-1899Article

Isolation and characterization of simian immunodeficiency virus variants that are resistant to nonnucleoside reverse transcriptase inhibitorsISAKA, Y; MIKI, S; KAWAUCHI, S et al.Archives of virology. 2000, Vol 145, Num 12, pp 2481-2492, issn 0304-8608Article

Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients : Evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trialJOLY, Véronique; MORONI, Mauro; WILKINS, Edmund G. L et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 11, pp 3155-3157, issn 0066-4804Article

The role of non-nucleoside reverse transcriptase inhibitors (NNRTIS) in the therapy of HIV-1 infectionDE CLERCQ, E.Antiviral research. 1998, Vol 38, Num 3, pp 153-179, issn 0166-3542Conference Paper

Identification of the metabolites of the HIV-1 reverse transcriptase inhibitor delavirdine in monkeysCHANG, M; SOOD, V. K; KLOOSTERMAN, D. A et al.Drug metabolism and disposition. 1997, Vol 25, Num 7, pp 814-827, issn 0090-9556Article

Metabolism of the HIV-1 reverse transcriptase inhibitor delavirdine in miceCHANG, M; SOOD, V. K; WILSON, G. J et al.Drug metabolism and disposition. 1997, Vol 25, Num 7, pp 828-839, issn 0090-9556Article

In-vitro selection of HIV-1 variants resistant to non-nucleoside reverse transcriptase inhibitors in monocyte-derived macrophagesBEEN-TIKTAK, A. M. M; DE HAAS, C. J. C; DE GRAAF, L et al.Journal of antimicrobial chemotherapy (Print). 1997, Vol 40, Num 6, pp 847-853, issn 0305-7453Article

Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticlesKUO, Yung-Chih; SU, Fu-Lung.International journal of pharmaceutics. 2007, Vol 340, Num 1-2, pp 143-152, issn 0378-5173, 10 p.Article

Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdineMCCANCE-KATZ, Elinore F; MOODY, David E; RAINEY, Petrie M et al.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, S224-S234, SUP4Conference Paper

Pharmacokinetic interaction between amprenavir and delavirdine after multiple-dose administration in healthy volunteersJUSTESEN, Ulrik S; KLITGAARD, Niels A; BROSEN, Kim et al.British journal of clinical pharmacology. 2003, Vol 55, Num 1, pp 100-106, issn 0306-5251, 7 p.Article

Determination of delavirdine in very small volumes of plasma by high-performance liquid chromatography with fluorescence detectionCHENG, Ching-Ling; CHOU, Chen-Hsi; YOA-PU HU, Oliver et al.Journal of chromatography. B, Biomedical sciences and applications. 2002, Vol 769, Num 2, pp 297-303, issn 1387-2273Article

Simultaneous separation of 11 protease and reverse transcriptase inhibitors for human immunodeficiency virus therapy by co-electroosmotic capillary zone electrophoresisGUTLEBEN, Wolfgang; SCHERER, Karin; NGUYEN DUC TUAN et al.Journal of chromatography. 2002, Vol 982, Num 1, pp 153-161, issn 0021-9673, 9 p.Article